Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies
Laurent Poirot(Txcell (France)), Julianne Smith(Case Western Reserve University), Román Galetto(Txcell (France)), Martin Pulé(Autolus (United Kingdom)), Cécile Bas(Txcell (France)), Justin Eyquem(Gladstone Institutes), Isabelle Chion-Sotinel(Txcell (France)), Sophie Derniame(Txcell (France)), Agnès Gouble(Txcell (France)), Aymeric Duclert(Txcell (France)), Andrew M. Scharenberg(CTI BioPharma (Italy)), Laëtitia Lemaire(Txcell (France)), Cécile Schiffer-Mannioui(Txcell (France)), Diane Le Clerre(Txcell (France)), Sylvain Arnould(Servier (France)), Pierrick Potrel(Txcell (France)), Céline Lebuhotel(Txcell (France)), Gordon Weng-Kit Cheung(CRUK Lung Cancer Centre of Excellence), Karl S. Peggs(Royal London Hospital), Brian Philip(CRUK Lung Cancer Centre of Excellence)
Cited by 600
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k